MIMICT 2 test
Materials to Increase Minority Involvement in Clinical Trials (MIMICT) creates collaborative opportunities for clinical trial sites and health care providers. MIMICT delivers accurate, trusted, and understandable information designed to enable people with lupus to make informed decisions about participation in clinical trials.
Lupus Clinical Trials: What You Don’t Know Can Hurt You
- Did you know that African Americans are between two and three times more likely to contract (carry? suffer from?) lupus than non-Hispanic whites?
- Did you know that despite their greater risk, African Americans are significantly underrepresented in clinical trial opportunities for lupus-combatting initiatives?
- Did you know that providers can increase African Americans’ involvement in lupus clinical trials by referring to clinical trials as one of their patients’ treatment options for lupus?
This project was supported by Grant Numbers 1 CPIMP171138 and 1 CPIMP181166 from the U.S. Department of Health and Human Services office of Minority Health (HHS, OMH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS, OMH.